Ferinject Injectafer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ferinject injectafer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ferinject Injectafer Today - Breaking & Trending Today

Analyzing Zoetis (NYSE:ZTS) and Vifor Pharma (OTCMKTS:GNHAY)

Zoetis (NYSE:ZTS – Get Free Report) and Vifor Pharma (OTCMKTS:GNHAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership. Valuation and Earnings This table compares Zoetis and Vifor […] ....

United States , New Jersey , Sankt Gallen , Vifor Pharma , Ferinject Injectafer , Fresenius Kabi , Zoetis Inc , Get Free Report , Given Zoeti , Zoetis Daily , Nyse Zts , Stock Comparison , Stock Analysis ,

Brokers Review Prospects For CSL

Brokers remain generally upbeat on CSL and focus upon the earnings contribution from the Vifor Pharma acquisition ....

Ferinject Injectafer , Vifor Pharma , Mark Woodruff , Credit Suisse , Fresenius Medical Care , Ord Minnett , Fresenius Medical , Vifor Fresenius Medical Care Renal Pharma , Neutral Rated Credit Suisse ,

Vifor Pharma AG (OTCMKTS:GNHAY) Short Interest Up 100.0% in May

Vifor Pharma AG (OTCMKTS:GNHAY – Get Rating) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 200 shares, an increase of 100.0% from the May 15th total of 100 shares. Based on an average daily volume of 100 shares, the […] ....

United States , Ferinject Injectafer , Vifor Pharma , Vifor Pharma Company Profile Get Rating , Get Rating , Pharma Company Profile , Otcmkts Gnhay ,

Vifor Pharma AG (OTCMKTS:GNHAF) Short Interest Update

Vifor Pharma AG (OTCMKTS:GNHAF – Get Rating) was the target of a large drop in short interest in May. As of May 31st, there was short interest totalling 2,900 shares, a drop of 75.2% from the May 15th total of 11,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is […] ....

United States , Ferinject Injectafer , Vifor Pharma , Vifor Pharma Company Profile Get Rating , Get Rating , Pharma Company Profile , Otcmkts Gnhaf ,

Vifor Pharma (OTCMKTS:GNHAF) Price Target Raised to CHF 179

Vifor Pharma (OTCMKTS:GNHAF – Get Rating) had its price objective lifted by analysts at UBS Group from CHF 167 to CHF 179 in a research note issued on Tuesday, The Fly reports. Shares of GNHAF opened at $173.25 on Tuesday. The business’s fifty day simple moving average is $174.60 and its two-hundred day simple moving […] ....

United States , Ferinject Injectafer , Vifor Pharma , Vifor Pharma Company Profile Get Rating , Get Rating , Pharma Company Profile , Otcmkts Gnhaf , Boost Price Target , Ubs Group Ag ,